Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up

Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods. The retrospective study included 48 children with active sJIA in whom TCZ therapy was initiated because of the inefficiency of using...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk
פורמט:	Artigo
שפה:	Russo
יצא לאור:	IMA-PRESS LLC 2018-01-01
סדרה:	Современная ревматология
נושאים:	systemic juvenile idiopathic arthritis interleukin-6 tocilizumab remission
גישה מקוונת:	https://mrj.ima-press.net/mrj/article/view/793
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!